Terms: = Breast cancer AND CTCF, P49711, 10664, ENSG00000102974
109 results:
1. Telocinobufagin, a PLK1 suppressor that inhibits tumor growth and metastasis by modulating CDC25c and ctcf in HNSCC cells.
Li J; Ma R; Lv JL; Ren YS; Tan YJ; Wang HM; Wang ZE; Wang BS; Yu JN; Wang YL; Tian J; Zheng QS
Phytomedicine; 2024 May; 127():155440. PubMed ID: 38452691
[TBL] [Abstract] [Full Text] [Related]
2. DARDN: A Deep-Learning Approach for ctcf Binding Sequence Classification and Oncogenic Regulatory Feature Discovery.
Cho HJ; Wang Z; Cong Y; Bekiranov S; Zhang A; Zang C
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397134
[TBL] [Abstract] [Full Text] [Related]
3. Differential DNA methylation and ctcf binding between the ESR1 promoter a of MCF-7 and MDA-MB-231 breast cancer cells.
Montes-de-Oca-Fuentes EV; Jácome-López K; Zarco-Mendoza A; Guerrero G; Ventura-Gallegos JL; Juárez-Méndez S; Cabrera-Quintero AJ; Recillas-Targa F; Zentella-Dehesa A
Mol Biol Rep; 2024 Jan; 51(1):148. PubMed ID: 38236307
[TBL] [Abstract] [Full Text] [Related]
4. Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors.
Llinàs-Arias P; Ensenyat-Mendez M; Íñiguez-Muñoz S; Orozco JIJ; Valdez B; Salomon MP; Matsuba C; Solivellas-Pieras M; Bedoya-López AF; Sesé B; Mezger A; Ormestad M; Unzueta F; Strand SH; Boiko AD; Hwang ES; Cortés J; DiNome ML; Esteller M; Lupien M; Marzese DM
Mol Cancer; 2023 Nov; 22(1):190. PubMed ID: 38017545
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein.
Cai Z; Shi Q; Li Y; Jin L; Li S; Wong LL; Wang J; Jiang X; Zhu M; Lin J; Wang Q; Yang W; Liu Y; Zhang J; Gong C; Yao H; Yao Y; Liu Q
Sci Adv; 2023 Oct; 9(40):eadi3821. PubMed ID: 37801505
[TBL] [Abstract] [Full Text] [Related]
6. Spatiotemporal higher-order chromatin landscape of human histone gene clusters at histone locus bodies during the cell cycle in breast cancer progression.
Ghule PN; Boyd JR; Kabala F; Fritz AJ; Bouffard NA; Gao C; Bright K; Macfarlane J; Seward DJ; Pegoraro G; Misteli T; Lian JB; Frietze S; Stein JL; van Wijnen AJ; Stein GS
Gene; 2023 Jul; 872():147441. PubMed ID: 37094694
[TBL] [Abstract] [Full Text] [Related]
7. Microdeletion at ESR1 Intron 6 (DEL_6_75504) Is a Susceptibility Factor for Cryptorchidism and Hypospadias.
Masunaga Y; Fujisawa Y; Massart F; Spinelli C; Kojima Y; Mizuno K; Hayashi Y; Sasagawa I; Yoshida R; Kato F; Fukami M; Kamatani N; Saitsu H; Ogata T
J Clin Endocrinol Metab; 2023 Sep; 108(10):2550-2560. PubMed ID: 37010083
[TBL] [Abstract] [Full Text] [Related]
8. BAP18 facilitates ctcf-mediated chromatin accessible to regulate enhancer activity in breast cancer.
Sun G; Wei Y; Zhou B; Wang M; Luan R; Bai Y; Li H; Wang S; Zheng D; Wang C; Wang S; Zeng K; Liu S; Lin L; He M; Zhang Q; Zhao Y
Cell Death Differ; 2023 May; 30(5):1260-1278. PubMed ID: 36828916
[TBL] [Abstract] [Full Text] [Related]
9. Involvement of Xeroderma Pigmentosum Complementation Group G (XPG) in epigenetic regulation of T-Helper (T
Pal R; Rakshit S; Shanmugam G; Paul N; Bhattacharya D; Chatterjee A; Singh A; George M; Sarkar K
Immunobiology; 2022 Sep; 227(5):152259. PubMed ID: 36037675
[TBL] [Abstract] [Full Text] [Related]
10. 3D chromatin remodeling potentiates transcriptional programs driving cell invasion.
Lebeau B; Jangal M; Zhao T; Wong CK; Wong N; Cañedo EC; Hébert S; Aguilar-Mahecha A; Chabot C; Buchanan M; Catterall R; McCaffrey L; Deblois G; Kleinman C; Park M; Basik M; Witcher M
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2203452119. PubMed ID: 36037342
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.
Zhang L; Sun S; Zhao X; Liu J; Xu Y; Xu L; Song C; Li N; Yu J; Zhao S; Yu P; Fang F; Xie J; Ji X; Yu R; Ou Q; Zhao Z; Li M
Mol Oncol; 2022 Oct; 16(20):3689-3702. PubMed ID: 35971249
[TBL] [Abstract] [Full Text] [Related]
12. Somatic point mutations are enriched in non-coding RNAs with possible regulatory function in breast cancer.
Rezaie N; Bayati M; Hamidi M; Tahaei MS; Khorasani S; Lovell NH; Breen J; Rabiee HR; Alinejad-Rokny H
Commun Biol; 2022 Jun; 5(1):556. PubMed ID: 35672401
[TBL] [Abstract] [Full Text] [Related]
13. Comparative characterization of 3D chromatin organization in triple-negative breast cancers.
Kim T; Han S; Chun Y; Yang H; Min H; Jeon SY; Kim JI; Moon HG; Lee D
Exp Mol Med; 2022 May; 54(5):585-600. PubMed ID: 35513575
[TBL] [Abstract] [Full Text] [Related]
14. ctcf-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative breast cancer via Sponging miR-149-5p to Up-Regulate ctcf and CTNNB1 to Activate Wnt/β-Catenin Pathway.
Zhu S; Sun J; Liu X; Shao H; Feng C; Wang Z; Zheng X; Wei S
Mol Cell Biol; 2022 Jun; 42(6):e0018821. PubMed ID: 35499320
[TBL] [Abstract] [Full Text] [Related]
15. Pioneer transcription factors are associated with the modulation of DNA methylation patterns across cancers.
Lemma RB; Fleischer T; Martinsen E; Ledsaak M; Kristensen V; Eskeland R; Gabrielsen OS; Mathelier A
Epigenetics Chromatin; 2022 Apr; 15(1):13. PubMed ID: 35440061
[TBL] [Abstract] [Full Text] [Related]
16. Canonical WNT signaling-dependent gating of MYC requires a noncanonical ctcf function at a distal binding site.
Chachoua I; Tzelepis I; Dai H; Lim JP; Lewandowska-Ronnegren A; Casagrande FB; Wu S; Vestlund J; Mallet de Lima CD; Bhartiya D; Scholz BA; Martino M; Mehmood R; Göndör A
Nat Commun; 2022 Jan; 13(1):204. PubMed ID: 35017527
[TBL] [Abstract] [Full Text] [Related]
17. Three-Dimensional Genome Organization in breast and Gynecological cancers: How Chromatin Folding Influences Tumorigenic Transcriptional Programs.
Nuñez-Olvera SI; Puente-Rivera J; Ramos-Payán R; Pérez-Plasencia C; Salinas-Vera YM; Aguilar-Arnal L; López-Camarillo C
Cells; 2021 Dec; 11(1):. PubMed ID: 35011637
[TBL] [Abstract] [Full Text] [Related]
18. A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations.
Zaurin R; Ferrari R; Nacht AS; Carbonell J; Le Dily F; Font-Mateu J; de Llobet Cucalon LI; Vidal E; Lioutas A; Beato M; Vicent GP
Nucleic Acids Res; 2021 Dec; 49(22):12716-12731. PubMed ID: 34850111
[TBL] [Abstract] [Full Text] [Related]
19. ctcf and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
Wong KM; Song J; Wong YH
Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746
[TBL] [Abstract] [Full Text] [Related]
20. Estrogen Receptor Alpha Mutations in breast cancer Cells Cause Gene Expression Changes through Constant Activity and Secondary Effects.
Arnesen S; Blanchard Z; Williams MM; Berrett KC; Li Z; Oesterreich S; Richer JK; Gertz J
Cancer Res; 2021 Feb; 81(3):539-551. PubMed ID: 33184109
[TBL] [Abstract] [Full Text] [Related]
[Next]
